# Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer

> **NCT06768463** · NA · RECRUITING · sponsor: **University Medical Center Ho Chi Minh City (UMC)** · enrollment: 250 (estimated)

## Conditions studied

- Metastatic Gastric Cancer
- Gastric Cancer
- Systemic Therapy
- Cytoreductive Gastrectomy

## Interventions

- **PROCEDURE:** Cytoreductive Gastrectomy

## Key facts

- **NCT ID:** NCT06768463
- **Lead sponsor:** University Medical Center Ho Chi Minh City (UMC)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2027-07-10
- **Final completion:** 2027-12-10
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2025-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06768463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06768463, "Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06768463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*